Does TOLVAPTAN Cause Therapy cessation? 121 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 121 reports of Therapy cessation have been filed in association with TOLVAPTAN (Jynarque). This represents 1.3% of all adverse event reports for TOLVAPTAN.
121
Reports of Therapy cessation with TOLVAPTAN
1.3%
of all TOLVAPTAN reports
8
Deaths
49
Hospitalizations
How Dangerous Is Therapy cessation From TOLVAPTAN?
Of the 121 reports, 8 (6.6%) resulted in death, 49 (40.5%) required hospitalization, and 1 (0.8%) were considered life-threatening.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOLVAPTAN. However, 121 reports have been filed with the FAERS database.
What Other Side Effects Does TOLVAPTAN Cause?
Death (800)
Thirst (624)
Off label use (560)
Renal impairment (534)
Underdose (448)
Product use in unapproved indication (446)
Wrong technique in product usage process (426)
Polyuria (390)
Product dose omission issue (379)
Inappropriate schedule of product administration (376)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which TOLVAPTAN Alternatives Have Lower Therapy cessation Risk?
TOLVAPTAN vs TOPAMAX
TOLVAPTAN vs TOPIRAMATE
TOLVAPTAN vs TOPOTECAN
TOLVAPTAN vs TOPOTECAN\TOPOTECAN
TOLVAPTAN vs TOPROL